-
Loading metrics
Open Access
Peer-reviewed
Research Article
Phase II trial of cisplatin, gemcitabine and pembrolizumab for platinum-resistant ovarian cancer
-
Christine S. Walsh ,
Roles Conceptualization, Data curation, Formal analysis, Funding acquisition, Investigation, Methodology, Project administration, Writing – original draft
* E-mail: christine.walsh@cshs.org
Current address: Department of Obstetrics and Gynecology, University of Colorado, Aurora, Colorado, United States of America
Affiliations Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, Cedars-Sinai Medical Center, Los Angeles, California, United States of America, Cedars-Sinai Cancer, Cedars-Sinai Medical Center, Los Angeles, California, United States of America
⨯ -
Mitchell Kamrava,
Roles Investigation, Writing – review & editing
Affiliations Cedars-Sinai Cancer, Cedars-Sinai Medical Center, Los Angeles, California, United States of America, Department of Radiation Oncology, Cedars-Sinai Medical Center, Los Angeles, California, United States of America
⨯ -
Andre Rogatko,
Roles Formal analysis, Methodology, Writing – review & editing
Affiliations Cedars-Sinai Cancer, Cedars-Sinai Medical Center, Los Angeles, California, United States of America, Biostatistics and Bioinformatics Research Center, Cedars-Sinai Medical Center, Los Angeles, California, United States of America
⨯ -
Sungjin Kim,
Roles Formal analysis, Writing – review & editing
Affiliations Cedars-Sinai Cancer, Cedars-Sinai Medical Center, Los Angeles, California, United States of America, Biostatistics and Bioinformatics Research Center, Cedars-Sinai Medical Center, Los Angeles, California, United States of America
⨯ -
Andrew Li,
Roles Investigation, Writing – review & editing
Affiliations Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, Cedars-Sinai Medical Center, Los Angeles, California, United States of America, Cedars-Sinai Cancer, Cedars-Sinai Medical Center, Los Angeles, California, United States of America
⨯ -
Ilana Cass,
Roles Investigation, Writing – review & editing
Current address: Department of Obstetrics and Gynecology, Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire, United States of America
Affiliations Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, Cedars-Sinai Medical Center, Los Angeles, California, United States of America, Cedars-Sinai Cancer, Cedars-Sinai Medical Center, Los Angeles, California, United States of America
⨯ -
Beth Karlan,
Roles Investigation, Writing – review & editing
Current address: Department of Obstetrics and Gynecology, David Geffen School of Medicine at UCLA, Los Angeles, California, United States of America
Affiliations Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, Cedars-Sinai Medical Center, Los Angeles, California, United States of America, Cedars-Sinai Cancer, Cedars-Sinai Medical Center, Los Angeles, California, United States of America
⨯ -
Bobbie J. Rimel
Roles Investigation, Writing – review & editing
Affiliations Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, Cedars-Sinai Medical Center, Los Angeles, California, United States of America, Cedars-Sinai Cancer, Cedars-Sinai Medical Center, Los Angeles, California, United States of America
⨯
Phase II trial of cisplatin, gemcitabine and pembrolizumab for platinum-resistant ovarian cancer
- Christine S. Walsh,
- Mitchell Kamrava,
- Andre Rogatko,
- Sungjin Kim,
- Andrew Li,
- Ilana Cass,
- Beth Karlan,
- Bobbie J. Rimel
- Published: June 3, 2021
- https://doi.org/10.1371/journal.pone.0252665